Kawanishi, Japan

Kosuke Aritake




Average Co-Inventor Count = 6.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Kawanishi, JP (2007 - 2013)
  • Suita, JP (2014)

Company Filing History:


Years Active: 2007-2014

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Kosuke Aritake

Introduction

Kosuke Aritake is a notable inventor based in Kawanishi, Japan. He has made significant contributions to the field of medical diagnostics, particularly in relation to muscle degenerative diseases and eosinophilic inflammatory diseases. With a total of 3 patents, Aritake's work is paving the way for advancements in early detection and treatment efficacy.

Latest Patents

Aritake's latest patents include a method for detecting muscle degenerative diseases and a method for determining therapeutic efficacy on these diseases. The first patent focuses on the early detection of muscle degenerative diseases by measuring 11,15-dioxo-9α-hydroxy-2,3,4,5-tetranorprostan-1,20-dioic acid, commonly referred to as 'Tetranor-PGDM', in samples isolated from subjects. The second patent provides a method for diagnosing the severity of eosinophilic inflammatory diseases, such as nasal polyps, and predicting the recurrence of these conditions.

Career Highlights

Throughout his career, Aritake has worked with esteemed organizations, including the Osaka Bioscience Institute and Taiho Pharmaceutical Company Limited. His experience in these institutions has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Aritake has collaborated with notable colleagues, including Yoshihiro Urade and Naomi Eguchi. Their combined expertise has contributed to the advancement of research in their respective fields.

Conclusion

Kosuke Aritake's innovative work in medical diagnostics highlights the importance of early detection and effective treatment methods. His contributions are significant in the ongoing efforts to improve healthcare outcomes for patients with degenerative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…